Immunosuppressive and cytotoxic chemotherapy: long-term complications.
D000477:Alkylating Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001379:Azathioprine / Q000009:adverse effects; D001761:Bleomycin / Q000009:adverse effects; D002066:Busulfan / Q000009:adverse effects; D002273:Carcinogens; D056486:Chemical and Drug Induced Liver Injury; D003630:Daunorubicin / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D005333:Fetus / Q000187:drug effects; D005493:Folic Acid Antagonists / Q000009:adverse effects; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007247:Infertility, Female / Q000139:chemically induced; D007248:Infertility, Male / Q000139:chemically induced; D008099:Liver / Q000187:drug effects; D008171:Lung Diseases / Q000139:chemically induced; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D009205:Myocarditis / Q000139:chemically induced; D009369:Neoplasms / Q000139:chemically induced / Q000188:drug therapy*; D010053:Ovary / Q000187:drug effects; D011247:Pregnancy; D011344:Procarbazine / Q000009:adverse effects; D013311:Streptozocin / Q000009:adverse effects; D013737:Testis / Q000187:drug effects; D014570:Urologic Diseases / Q000139:chemically induced
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D002273:Carcinogens; D005493:Folic Acid Antagonists; D007166:Immunosuppressive Agents; D001761:Bleomycin; D011344:Procarbazine; D013311:Streptozocin; D004317:Doxorubicin; D015122:Mercaptopurine; D002066:Busulfan; D001379:Azathioprine; D008727:Methotrexate; D003630:Daunorubicin